Ligand Pharmaceuticals Incorporated (25) | Development Agreements (1)
- Development Funding and Royalties Agreement, dated December 13, 2018, by and between Ligand Pharmaceuticals Incorporated and Palvella Therapeutics, Inc (Filed With SEC on February 28, 2019)
